Noucor Health — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Noucor Health is a private, integrated pharmaceutical company with a long industrial heritage, now backed by MCH Private Equity and family offices. It combines R&D of novel drugs with a robust generics business and contract manufacturing services, operating across the entire value chain from API synthesis to finished product commercialization. With over 500 employees and a strong sustainability focus, the company aims to be a trusted strategic B2B partner in the global healthcare ecosystem. Its operations are split between a fine chemicals plant (Urquima) and facilities for pharmaceuticals and food supplements.

Small Molecules

Technology Platform

Integrated chemical-pharmaceutical development and manufacturing value chain, encompassing API synthesis, formulation, GMP production of oral solids/semi-solids, and full regulatory/commercialization support.

Opportunities

The growing demand for reliable CDMO services and generic APIs, especially from companies seeking European manufacturing bases, presents a significant opportunity.

Additionally, advancing its internal NCE pipeline into clinical stages could dramatically increase company valuation and transition it into a novel drug developer.

Risk Factors

Key risks include high competition and margin pressure in the generics and CDMO sectors, the inherent risk of failure and high cost associated with its proprietary NCE development program, and operational risks related to maintaining quality and compliance across three manufacturing plants and a global supply chain.

Competitive Landscape

Noucor competes in fragmented, competitive markets. In generics and APIs, it faces large global players (e.g., Teva, Sandoz) and low-cost Asian manufacturers. In CDMO, it competes with other integrated European CDMOs and specialized firms. Its differentiation lies in its vertical integration, B2B focus, and sustainability positioning.

More companies in Small Molecule Drugs →More companies in Spain →